- October 30th, 2020
- Category: press
The DRAGON project: fighting Coronavirus pandemics
The DRAGON project led by Radiomics in partnership with 18 high-tech SMEs, academic research institutes, biotech and pharma partners, affiliated patient-centred organisations and professional societies from Belgium, Italy, the Netherlands, Switzerland and the UK, has been selected for funding by the Innovative Medicines Initiative (IMI), with an evaluation score placing it in the 95% percentile.
The DRAGON project: fighting Coronavirus pandemics
The DRAGON project led by Radiomics in partnership with 18 high-tech SMEs, academic research institutes, biotech and pharma partners, affiliated patient-centred organisations and professional societies from Belgium, Italy, the Netherlands, Switzerland and the UK, has been selected for funding by the Innovative Medicines Initiative (IMI), with an evaluation score placing it in the 95% percentile.
Diagnosing COVID-19 and, crucially, predicting how the disease will progress in different patients, remains a challenge. The DRAGON project aims to use artificial intelligence (AI) and machine learning to develop a decision support system capable of delivering a more precise coronavirus diagnosis and more accurate predictions of patient outcomes.
The project will draw on new and existing data and sample collection efforts, including CT (computed tomography) scans to carry out detailed profiling of patients. They will then use AI technology to transform this information into a precision medicine approach that will help clinicians and patients with decision making around treatments.
Underpinning all of this will be a federated machine learning system that will allow the use of data from a range of international sources while complying with the EU’s General Data Protection Regulation (GDPR).
A patient and public advisory group will provide advice and input throughout the project.
![[:swvar:ufile:1:description:]](/swfiles/files/logo-radiomics.svg?nc=1709282693){kind=logo}